Thomas Woiwode Aligos Therapeutics, Inc. (ALGS) insider trading activity

ALGS Quotes by TradingView

Thomas Woiwode is Director of Aligos Therapeutics, Inc.. Currently has a direct ownership of 4,452 shares of ALGS, which is worth approximately $80,536. The most recent transaction as insider was on Jun 11, 2021, when has been sold 2,226 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.45K
0% 3M change
0% 12M change
Total Value Held $80,536

Thomas Woiwode Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 11 2021
BUY
Other acquisition or disposition
-
2,226 Added 33.33%
4,452 Common Stock
Apr 26 2021
BUY
Other acquisition or disposition
-
2,226 Added 50.0%
2,226 Common Stock

Also insider at

CRSP
CRISPR Therapeutics AG Healthcare
Director
ADVM
Adverum Biotechnologies, Inc. Healthcare
Director
GRTS
Gritstone bio, Inc. Healthcare
Director
PASG
Passage BIO, Inc. Healthcare
Director
TPST
Tempest Therapeutics, Inc. Healthcare
Director
TW

Thomas Woiwode

Director
Cambridge, MA

Track Institutional and Insider Activities on ALGS

Follow Aligos Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ALGS shares.

Notify only if

Insider Trading

Get notified when an Aligos Therapeutics, Inc. insider buys or sells ALGS shares.

Notify only if

News

Receive news related to Aligos Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ALGS